EUCTR2021-000291-11-AT进行中（未招募）1 期
Characterization of immune responsiveness after SARS-CoV-2 Vaccination in patients with Immunodeficiency or immunosuppressive therapy (COVID-19) - Immune response after SARS-CoV-2 vaccination (COVID-19)
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male and female subjects will be eligible for participation in this study if they:
- •Are =18 years on the day of screening
- •Have a disease that is associated with a well characterized immunodeficiency (study population)
- •Treated with an immunosuppressive therapy (study population)
- •Have an immune-mediated disease without an immunosuppressive therapy, e.g. IBD patients solely with 5-ASA treatment (study population)
- •Are clinically healthy and not vaccinated with a SARS-CoV-2 vaccine (control group, age and sex-matched)
- •Have an understanding of the study, agree to its provisions, and give written informed consent prior to study entry
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 2000
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 1000
排除标准
- •Are not willing to get SARS-CoV-2 Vaccination
研究者
相似试验
招募中
不适用
CIMAvax-EGF in different maintenance schemeson small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesNSCLCRPCEC00000368Center of Molecular Immunology (CIM)42
招募中
不适用
Characterisation of the immune response after spinal cord injurySpinal cord injuryNL-OMON55320niversiteit Hasselt102
尚未招募
不适用
Study of the immune system following spinal cord injurySpinal cord injuryNL-OMON26426ot applicable102
进行中（未招募）
不适用
A Clinical trial to analysis of immune profile following neoadjuvant chemotherapy in colorectal liver metastases patientsNeoplasmsKCT0003474Asan Medical Center20
进行中（未招募）
1 期
Evaluation of immunological response following a revaccination with a non-conjugated pneumococcal vaccine boosted or not by a conjugated pneumococcal vaccine in splenectomised patients (SPLENEVAC-2)Asplenic patients at risk for invasive pneumococcal diseasesMedDRA version: 20.0Level: PTClassification code 10041642Term: SplenectomySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2018-003068-29-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)56